Routine compliance certificate on dematerialisation for Q2 FY27
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 1.6 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Norris Medicines has filed a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate, given by the company Registrar and Transfer Agent Purva Sharegistry India, confirms that share certificates received from depository participants for dematerialisation during the quarter were accepted or rejected within the prescribed timelines and that the names of the depositories were substituted as registered owners in the company records. Small-scale dematerialisation of roughly 16 lots involving around 1,050 shares is listed.
Purely procedural compliance filing with no material effect on shareholders or the stock price.